Evidence for the association of human papillomavirus infection and cutaneous squamous cell carcinoma in immunocompetent individuals

Archives of Dermatology

Volumn 139, Issue 7, 2003, Pages 890-894

  Masini, Cinzia ^a,d   Fuchs, Pawel G ^b   Gabrielli, Fabrizio ^a   Stark, Sabine ^b   Sera, Francesco ^a   Ploner, Miriam ^b   Melchi, Carmelo Franco ^a   Primavera, Grazia ^a   Pirchio, Giulio ^a   Orietta, Picconi ^a   Petasecca, Pierpaolo ^a   Cattaruzza, Maria Sofia ^a,c   Pfister, Herbert J ^b   Abeni, Damiano ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^b UNIVERSITY OF COLOGNE   (Germany)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d Clinical Epidemiology Unit   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; BODY SURFACE; CANCER RISK; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; EYE COLOR; FAMILY HISTORY; FEMALE; GENETIC PREDISPOSITION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENCE; INTERVIEW; ITALY; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RISK FACTOR; SEBORRHEIC KERATOSIS; SERODIAGNOSIS; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE; VERRUCA VULGARIS; VIRUS STRAIN; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; CAPSID PROTEINS; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOCOMPETENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; SKIN NEOPLASMS; TUMOR VIRUS INFECTIONS;

EID: 0041807961     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.139.7.890     Document Type: Article

References (40)

1. Alani RM, Munger K. Human papillomaviruses and associated malignancies. J Clin Oncol. 1998;16:330-337.
2. Human Papillomaviruses. Lyon, France: International Agency for Research on Cancer; 1995, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol 64.
3. Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J Natl Cancer Inst. 1995;87:796-802.
4. zur Hausen H. Papillomavirus infections - a major cause of human cancers. Biochem Biophys Acta. 1996;1288:F55-F78.
5. Mork J, Lie AK, Glattre E, et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med. 2001;344: 1125-1131.
6. Klussmann JP, Weissenborn SJ, Wieland U, et al. Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer. 2001; 92:2875-2884.
7. Fuchs PG, Pfister H. Papillomaviruses in epidermodysplasia verruciformis. In: Lacey C, ed. Papillomavirus Reviews: Current Research on Papillomaviruses. Leeds, England: Leeds University Press; 1996:253-262.
8. de Villiers E, Lavergne D, McLaren K, Benton EC. Prevailing papillomavirus types in non-melanoma carcinomas of the skin in renal allograft recipients. Int J Cancer. 1997;73:356-361.
9. Berkhout RJ, Bouwes Bavinck JN, ter Schegget J. Persistence of human papillomavirus DNA in benign and (pre)malignant skin lesions from renal transplant recipients. J Clin Microbiol. 2000;38:2087-2096.
10. de Jong-Tieben LM, Berkhout RJ, ter Schegget J, et al. The prevalence of human papillomavirus DNA in benign keratotic skin lesions of renal transplant recipients with and without a history of skin cancer is equally high. Transplantation. 2000;69:44-49.
11. Arends MJ, Benton EC, McLaren KM, Hunter JAA, Bird CC. Renal allograft recipients with high susceptibility to cutaneous malignancy have an increased prevalence of human papillomavirus DNA in skin tumours and a greater risk of anogenital malignancy. Br J Cancer. 1997;75:722-728.
12. Burk RD, Kadish AS. Treasure hunt for human papillomaviruses in nonmelanoma skin cancers. J Natl Cancer Inst 1996;88:781-782.
13. Shamanin V, zur Hausen H, Lavergne D, et al. Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and non-immunosuppressed patients. J Natl Cancer Inst. 1996;88:802-811.
14. Pfister H, Ter Schegget J. Role of HPV in cutaneous premalignant and malignant tumors. Clin Dermatol. 1997;15:335-347.
15. Harwood CA, McGregor JM, Proby CM, Breuer J. Human papillomavirus and the development of non-melanoma skin cancer. J Clin Pathol. 1999;52:249-253.
16. Boxman IL, Russell A, Mulder LH, Bavinck JN, Schegget JT, Green A, for the Nambour Skin Cancer Prevention Study Group. Case-control study in a subtropical Australian population to assess the relation between non-melanoma skin cancer and epidermodysplasia verruciformis human papillomavirus DNA in plucked eyebrow hairs. Int J Cancer. 2000;86:118-121.
17. Jackson S, Storey A. E6 proteins from diverse cutaneous HPV types inhibit apoptosis in response to UV damage. Dncogene. 2000;19:592-598.
18. Carter JJ, Galloway DA. Humoral immune response to human papillomavirus infection. Clin Dermatol. 1997;15:249-259.
19. Baird P. Serological evidence for the association of papillomavirus and cervical neoplasia. Lancet. 1983;2:17-18.
20. Nonnenmacher B, Kruger-Kjaer S, Svare EI, et al. Seroreactivity to HPV16 virus-like particles as a marker for cervical cancer risk in high-risk populations. Int J Cancer. 1996;68:704-709.
21. Wideroff L, Schiffman MH, Hoover R, et al. Epidemiologic determinants of seroreactivity to human papillomavirus (HPV) type 16 virus-like particles in cervical HPV-16 DNA-positive and -negative women. J Infect Dis. 1996;174:937-943.
22. Stark S, Petridis AK, Ghim SJ, et al. Prevalence of antibodies against virus-like particles of epidermodysplasia verruciformis-associated HPV8 in patients at risk of skin cancer. J Invest Dermatol. 1998;111:696-701.
23. Bouwes Bavinck JN, Stark S, Petridis AK, et al. The presence of antibodies against virus-like particles of epidermodysplasia verruciformis-associated human papillomavirus type 8 in patients with actinic keratoses. Br J Dermatol. 2000;142: 103-109.
24. Wieland U, Ritzkowsky A, Stoltidis M, et al. Papillomavirus DNA in basal cell carcinomas of immunocompetent patients. J Invest Dermatol. 2000;115:124-128.
25. Kremsdorf D, Favre M, Jablonska S, et al. Molecular cloning and characterization of the genomes of nine newly recognized human papillomavirus types associated with epidermodysplasia verruciformis. J Virol. 1984;52:1013-1018.
26. Kozak M. Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs. Nucleic Acids Res. 1984;12:857-872.
27. Norusis MJ. SPSS for Windows Professional and Advanced Statistics, Release 8.0. Chicago, III: SPSS Inc; 1998.
28. Stata Corp. Stata Statistical Software: Release 4.0 for Windows 95. College Station, Tex: Stata Corp; 1995.
29. English DR, Armstrong BK, Kricker A. Reproducibility of reported measurements of sun exposure in a case-control study. Cancer Epidemiol Biomarkers Prev. 1998;7:857-863.
30. Weinstock MA, Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE. Recall (report) bias and reliability in the retrospective assessment of melanoma risk. Am J Epidemiol. 1991;133:240-245.
31. Cockburn M, Hamilton A, Mack T. Recall bias in self-reported melanoma risk factors. Am J Epidemiol. 2001;153:1021-1026.
32. Silins I, Wang Z, Avall-Lundqvist E, et al. Serological evidence for protection by human papillomavirus (HPV) type 6 infection against HPV type 16 cervical carcinogenesis. J Gen Virol. 1999;80(pt 11):2931-2936.
33. Schwartz SM, Daling JR, Doody DR, et al. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst. 1998; 90:1626-1636.
34. Favre M, Majewski S, Noszczyk B, et al. Antibodies to human papillomavirus type 5 are generated in epidermal repair processes. J Invest Dermatol. 2000;114: 403-407.
35. Tsambaos D, Monastirli A, Kapranos N, et al. Detection of human papillomavirus DNA in nongenital seborrhoeic keratoses. Arch Dermatol Res. 1995;287: 612-615.
36. Yeatman JM, Kilkenny M, Marks R. The prevalence of seborrhoeic keratoses in an Australian population. Br J Dermatol. 1997;137:411-414.
37. Sciocchetti G, Clemente GF, Ingrao G, Sacco F. Results of a survey on radioactivity of building materials in Italy. Health Phys. 1983;45:385-388.
38. Sperati A, Abeni DD, Tagesson C, Forastiere F, Miceli M, Axelson O. Exposure to indoor background radiation and urinary concentrations of 8-hydroxydeoxyguanosine, a marker of oxidative DNA damage. Environ Health Perspect. 1999;107:213-215.
39. Etherington DJ, Pheby DF, Bray FI. An ecological study of cancer incidence and radon levels in South West England. Eur J Cancer. 1996;32A:1189-1197.
40. Eatough JP, Henshaw DL. The theoretical risk of non-melanoma skin cancer from environmental radon exposure. J Radiol Prot. 1995;15:45-51.